HUMAN PERFORMANCE CLINIC

Neuroscience, Meet Clinical Psychology

 

Headaches and Migraine


Walker (2011) reported on 71 recurrent migraine cases who consulted a neurological practice. Forty-six of the patients consented to QEEG-guided neurofeedback treatment, whereas 25 chose drug treatment. Excess higher frequency beta was present in all cases. At 1-year follow-up, 54% of the neurofeedback group experienced complete cessation of migraines compared with no one in the medication treatment group. In the neurofeedback group, 39% experienced a reduction of greater than 50% in migraines (compared with 8% with drug treatment), and a reduction of less than 50% was found in 4% of patients (compared to 20% with medication treatment). Sixty-eight percent of the medication treatment group reported no change in headache frequency, whereas only one patient (2%) receiving neurofeedback reported no reduction in frequency.

 

Siniatchkin, Hierundar, Kropp, Gerber, and Stephani (2000) found a significant reduction in the number of days per month with a migraine in children treated with slow cortical potentials training versus a waitlist control group. Carmen (2004) reported improvement of more than 90% in migraine sufferers who completed at least six sessions of HEG training. For Stokes and Lappin (2010), 70% of migraine patients experienced at least a 50% reduction in frequency on more than 1-year follow-up from a combination of 40 neurofeedback sessions combined with HEG training. Tansey (1991a) published four case reports. Although encouraging, further controlled research is needed.

 

3800 N. Wilke Suite 160

Arlington Heights, IL 60004

224-636-6333